Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation In Early Phase Might Overcome the Adverse Prognosis of Acute Myeloid Leukemia with Translocation t(6;9)(p23;q34)/DEK-NP214(CAN) Rearrangement. A Retrospective Analysis From the Acute Leukemia Working Party of EBMT

Jordi Esteve, MD, Myriam Labopin, MD, Gerard Socie, MD, PhD, Per T. Ljungman, MD, PhD, Johan Maertens, Antonius V.M.B. Schattenberg, MD, PhD, Sebastien Maury, MD, Jean-Pierre Jouet, MD, Emmanuelle Polge, Vanderson Rocha, Mohamad Mohty, MD, PhD

Blood (2010) 116 (21): 3501.

https://doi.org/10.1182/blood.V116.21.3501.3501

Published: 2010

Journal Articles

Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplant: May We Predict Graft vs Leukemia without Graft vs Host Disease?.

Cesare Guglielmi, Stefania Bergantini, Simona Iacobelli, Anja van Biezen, Eduardo Olavarria, Alois Gratwohl, Antonius V.M.B. Schattenberg, Leo F. Verdonck, Dietger W. Niederwieser, T.M. de Witte, for the Chronic Leukemia Working Party of the EBMT

Blood (2006) 108 (11): 263.

https://doi.org/10.1182/blood.V108.11.263.263

Published: 2006

Journal Articles

The Balance in Chimerism between T Cells and Blood Dendritic Cells in Relapsed CML Patients Influences the Induction of Alloreactivity Following Donor Lymphocyte Infusion.

Henriette Levenga, Rob Woestenenk, Antonius V.M.B. Schattenberg, Frans Maas, Joop H. Jansen, Reinier Raymakers, Pieter H.M. De Mulder, Nicolaas Schaap, T.M. de Witte, Harry Dolstra

Blood (2006) 108 (11): 5139.

https://doi.org/10.1182/blood.V108.11.5139.5139

Published: 2006

Journal Articles

Donor Lymphocyte Infusions from Unrelated Donors for Treatment of Relapsed Chronic Myelogenous Leukemia: Importance of Initial Cell Dose.

Bernd Hertenstein, Elke Dammann, Matthias Eder, Jane Apperley, Juergen Finke, Antonius V.M.B. Schattenberg, Kimmo Porkka, Bo Bjoerkstrand, Dietger W. Niederwieser, Cesare Guglielmi

Blood (2005) 106 (11): 2055.

https://doi.org/10.1182/blood.V106.11.2055.2055

Published: 2005

Journal Articles

Outcome of Patients Developing GVHD after DLI for CML Relapse from HLA-Identical Sibling or VUD HSCT.

Yves Chalandon, Christoph Schmid, Kimmo Porkka, Alvaro Urbano-Ispizua, Bernd Hertenstein, Francesco Dazzi, Eduardo Olavarria, Jane Apperley, Per T. Ljungman, Antonius V.M.B. Schattenberg, Stig Lenhoff, Peter Jacobs, Jurgen Finke, Dietger W. Niederwieser, Cesare Guglielmi

Blood (2005) 106 (11): 1817.

https://doi.org/10.1182/blood.V106.11.1817.1817

Published: 2005

Journal Articles

High Rates of Molecular Response and Low Incidence of Mutations in Patients Treated with Newly Diagnosed Chronic Myeloid Leukemia (CML) Treated with a Dose-Escalated Combination of Imatinib and Cytarabin.

Jan J. Cornelissen, MD, PhD, Peter Valk, PhD, Gregor E.G. Verhoef, MD, PhD, Wim M. Smit, MD, PhD, Marinus van Marwijk-Kooij, MD, PhD, Shulamit Wittebol, MD, Marinus H.J. van Oers, MD, PhD, Hanneke C. Kluin-Nelemans, MD, PhD, Bob Lowenberg, MD, PhD, Roelof Willemze, MD, PhD, Antonius V.M.B. Schattenberg, MD, PhD, Gert Ossenkoppele, MD, PhD

Blood (2004) 104 (11): 19.

https://doi.org/10.1182/blood.V104.11.19.19

Published: 2004

NARROW

Allogeneic Hematopoietic Stem-Cell Transplantation In Early Phase Might Overcome the Adverse Prognosis of Acute Myeloid Leukemia with Translocation t(6;9)(p23;q34)/DEK-NP214(CAN) Rearrangement. A Retrospective Analysis From the Acute Leukemia Working Party of EBMT

Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplant: May We Predict Graft vs Leukemia without Graft vs Host Disease?.

The Balance in Chimerism between T Cells and Blood Dendritic Cells in Relapsed CML Patients Influences the Induction of Alloreactivity Following Donor Lymphocyte Infusion.

Donor Lymphocyte Infusions from Unrelated Donors for Treatment of Relapsed Chronic Myelogenous Leukemia: Importance of Initial Cell Dose.

Outcome of Patients Developing GVHD after DLI for CML Relapse from HLA-Identical Sibling or VUD HSCT.

High Rates of Molecular Response and Low Incidence of Mutations in Patients Treated with Newly Diagnosed Chronic Myeloid Leukemia (CML) Treated with a Dose-Escalated Combination of Imatinib and Cytarabin.

Email alerts

ASH Publications

American Society of Hematology

Allogeneic Hematopoietic Stem-Cell Transplantation In Early Phase Might Overcome the Adverse Prognosis of Acute Myeloid Leukemia with Translocation t(6;9)(p23;q34)/DEK-NP214(CAN) Rearrangement. A Retrospective Analysis From the Acute Leukemia Working Party of EBMT

Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplant: May We Predict Graft vs Leukemia without Graft vs Host Disease?.

The Balance in Chimerism between T Cells and Blood Dendritic Cells in Relapsed CML Patients Influences the Induction of Alloreactivity Following Donor Lymphocyte Infusion.

Donor Lymphocyte Infusions from Unrelated Donors for Treatment of Relapsed Chronic Myelogenous Leukemia: Importance of Initial Cell Dose.

Outcome of Patients Developing GVHD after DLI for CML Relapse from HLA-Identical Sibling or VUD HSCT.

High Rates of Molecular Response and Low Incidence of Mutations in Patients Treated with Newly Diagnosed Chronic Myeloid Leukemia (CML) Treated with a Dose-Escalated Combination of Imatinib and Cytarabin.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only